Navigation Links
A Breakthrough for Migraines, PMS and PCOS!
Date:12/23/2010

LOS ANGELES, Dec. 23, 2010 /PRNewswire/ -- In a world where millions suffer daily from the debilitating pain of migraine headaches, one name stands out as the definitive leader in natural, safe and effective treatment.  MigreLief by Akeso Health Sciences.

Now, patients are raving about the amazing results of the new breakthrough product from Akeso.  MigreLief+M (Menstrual) is the first of its kind supplement aimed at preventing migraines and other symptoms associated with a woman's menstrual cycle.

"There is a direct relationship between hormones and headaches," explains Curt Hendrix M.S. C.C.N., C.N.S., scientist and creator of MigreLief+M. "Headaches in women, particularly migraines, have been related to changes in the levels of the female hormones estrogen and progesterone before, during and after a woman's menstrual cycle.  These hormone levels fluctuate dramatically and are associated with a large percentage of migraines in women."

The release of MigreLief+M is life-changing news, not only for migraine sufferers but also for women who experience PMS symptoms such as cravings, breast tenderness, bloating, cramps, depression and irritability.  The active ingredients in this menstrually targeted MigreLief have been shown to not only balance the hormonal fluctuations that lead to menstrual related migraines, but also significantly decrease PMS symptoms as well.

What is the secret to the success of world renowned MigreLief? "The ingredients that are used are continuously monitored for quality and integrity by independent analytical laboratories throughout the manufacturing process. These ingredients are then used in the exact form and dose proven effective in human clinical studies.  Our supplements are of higher quality than those currently on the market because of this exacting scientific attention to purity and potency."

MigreLief+M is no exception and promises to be another winner with a multitude of added benefits:

  • Same reliable migraine treatment as MigreLief original formula with additional compounds to treat Menstrual migraines and alleviate many PMS and PCOS symptoms.
  • May be beneficial in reducing the occurrence of premenstrual acne.
  • Can be taken with your prescription migraine drugs and has no side-effects.
  • Regulates blood sugar balance that is a migraine trigger in many patients.
  • MigreLief Facebook and Twitter interface directly with consumers to support their ongoing health questions and needs.

  • All MigreLief products are available in select pharmacies and online at www.migrelief.com.  For more information and product samples contact sales@akesohealth.com.  

    About Akeso Health SciencesFounded by Curt Hendrix in 1992, Akeso is a family company dedicated to continuing research and breakthrough technologies for the development of patented supplements that have helped tens of thousands find the joy and peace of a new life without migraines.  The company consistently delivers innovative, leading edge solutions for migraineurs worldwide. (www.migrelief.com)Contact:Steve Hendrixsales@akesohealth.com (800) 758-8746DISCLAIMER: MigreLief™ is not intended to diagnose, treat, cure, or prevent any disease or illness.  Frequent use of this product may result in considerable weight loss.  Please consult with your licensed medical practitioner if you have, or suspect you may have, a health problem.


    '/>"/>

    SOURCE Akeso Health Sciences
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Bad Virus Put to Good Use: Breakthrough Batteries
    2. Bridging between Earth and space: technology breakthroughs for scientific progress
    3. Breakthrough in nanocrystals growth
    4. A revolutionary breakthrough in terahertz remote sensing
    5. European Nurse Society Calls to Action on Breakthrough Cancer Pain
    6. Breakthrough e-display means electronics with high speed, high readability and low power usage
    7. Medicago discovers breakthrough method of preparing plant derived recombinant proteins and VLPs and files two PCT patent applications
    8. Deloitte Recap Honors Sanofi-aventis and Exelixis With the Allicense 2010 Breakthrough Alliance Award for Early-Stage Collaboration in Cancer
    9. Breakthrough gene therapy prevents retinal degeneration
    10. New paper offers breakthrough on blinking molecules phenomenon
    11. A revolutionary breakthrough in terahertz remote sensing
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/17/2017)... MA (PRWEB) , ... January 17, 2017 , ... ... the completely re-engineered Drug Safety Technology Consortium™ (SafeTEC™), $3 million in investment towards ... validating these new tools and assays, and their applicability in drug safety assessment, ...
    (Date:1/16/2017)... ... January 16, 2017 , ... Appellate Court ... decision on the appeal filed by India-based Dishman Pharmaceutical & Chemical Ltd. company ... DPCL and one of its Dishman Group’s 100% wholly owned New Jersey-based subsidiary ...
    (Date:1/14/2017)...  The Alliance for Safe Biologic Medicines (ASBM) today ... final guidance on biologic naming: We ... the importance of distinct naming for all biologics, including ... biosimilars will bring to patients, including new treatment options ... of the Guidance dealing with suffix design remains at ...
    (Date:1/13/2017)... ... January 13, 2017 , ... FireflySci, in response to several ... new solutions for measurements where traditional cuvette applications are not convenient. For instance, ... oddly-shaped sample that would not fit into a typical cuvette inside a spectrophotometer. ...
    Breaking Biology Technology:
    (Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
    (Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
    (Date:12/12/2016)... Dec. 12, 2016  Researchers at Trinity College, ... graphene by combining the material with Silly Putty. The ... pressure detector able to sense pulse, blood pressure, ... spider.  The research team,s findings ... read here:  http://science.sciencemag.org/content/354/6317/1257 ...
    Breaking Biology News(10 mins):